Island medicine longitudinal cohort study: Rapid rise in chronic kidney disease in rural and remote communities.
chronic kidney disease
incidence
kidney replacement therapy
prevalence
rural health
Journal
Nephrology (Carlton, Vic.)
ISSN: 1440-1797
Titre abrégé: Nephrology (Carlton)
Pays: Australia
ID NLM: 9615568
Informations de publication
Date de publication:
27 Mar 2024
27 Mar 2024
Historique:
revised:
19
02
2024
received:
30
10
2023
accepted:
11
03
2024
medline:
27
3
2024
pubmed:
27
3
2024
entrez:
27
3
2024
Statut:
aheadofprint
Résumé
To determine the change in incidence and prevalence of chronic kidney disease (CKD) in rural and remote communities over the last decade. We examined the change in age-standardized incidence and prevalence in Tasmania between 2010 and 2020, using a linked dataset that included any adult with a creatinine test taken in a community laboratory during the study period (n = 581 513; 87.8% of the state's adult population). We defined CKD as two measures of eGFR <60 mL/min per 1.73 m State-wide age-standardized prevalence of CKD increased by 28% in the decade to 2020, from 516 to 659 per 10 000 population. Prevalence in men increased 31.3% and women 24.8%. The greatest increase in age-standardized prevalence was seen in rural or remote communities with an increase of 36.6% overall, but with considerable variation by community (range + 0.4% to +88.3%). The increase in the actual number of people with CKD in the decade to 2020 was 67%, with the number of women increasing by 58% and men by 79%. The age-standardized prevalence of CKD in rural and remote regions has increased considerably over the past decade, likely compounded by limited access to primary and secondary healthcare. These findings highlight the need to ensure healthcare resources are directed to areas of greatest need.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Tasmanian Community Fund
Organisme : Royal Hobart Hospital Research Foundation
Informations de copyright
© 2024 The Authors. Nephrology published by John Wiley & Sons Australia, Ltd on behalf of Asian Pacific Society of Nephrology.
Références
AIHW. Rural and Remote Health. Australian Institute of Health and Welfare; 2022 https://www.aihw.gov.au/reports/rural-remote-australians/rural-and-remote-health
Thomas SL, Wakerman J, Humphreys JS. Ensuring equity of access to primary health care in rural and remote Australia ‐ what core services should be locally available? Int J Equity Health. 2015;14:111.
Scholes‐Robertson N, Blazek K, Tong A, et al. Financial toxicity experienced by rural Australian families with chronic kidney disease. Nephrology (Carlton). 2023;28:456‐466.
Scholes‐Robertson NJ, Gutman T, Howell M, et al. Clinicians' perspectives on equity of access to dialysis and kidney transplantation for rural people in Australia: a semistructured interview study. BMJ Open. 2022;12(2):e052315.
AIHW. Chronic Kidney Disease: Australian Facts. Australian Institute of Health & Welfare; 2023 2023 (document CDK 20) https://www.aihw.gov.au/reports/chronic-kidney-disease/chronic-kidney-disease/contents/about
ANZDATA. 45th Annual Report. Adelaide, South Australia: 2022 2022. https://www.anzdata.org.au/report/anzdata-45th-annual-report-2022-data-to-2021
Changing the chronic kidney disease landscape: the economic benefits of early detection and treatment (report commissioned by Kidney Health Australia). Deloitte Access Economics. 2023.
Modified Monash Model. Australian Government: Department of Health and Aged Care. https://www.health.gov.au/topics/rural-health-workforce/classifications/mmm
ABS. Australian Demographic Statistics, Volume 3101.0. Canberra. 2018 https://www.abs.gov.au/AUSSTATS/abs@.nsf/Lookup/3101.0Main+Features1Jun%202019?OpenDocument
ABS. Australian Health Survey: Biomedical Results for Chronic Diseases, 2011–12. Australian Bureau of Statistics; 2013 (4364.0.55.005) https://www.abs.gov.au/AUSSTATS/abs@.nsf/DetailsPage/4364.0.55.0052011-12?OpenDocument
Saunder T, Kitsos A, Radford J, et al. Chronic kidney Disease in Tasmania: protocol for a data linkage study. JMIR Res Prot. 2020;9(9):e20160.
ABS. Australian Statistical Geography Standard (ASGS): Volume 1 – Main Structure and Greater Capital City Statistical Areas. Canberra. 2016 (1270.0.55.001) https://www.abs.gov.au/AUSSTATS/abs@.nsf/Lookup/1270.0.55.001Explanatory%20Notes1July%202016?OpenDocument
Population Health Areas. Public Health Information Development Unit (PHIDU) from Torrens University. https://phidu.torrens.edu.au/help‐and‐information/about‐our‐data/geographical‐structures/pha‐overview
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3(1):1‐150.
Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604‐612.
Jose MD, Otahal P, Kirkland G, Yu R, Blizzard L. Retrospective standardisation of serum creatinine identified changes in eGFR over time. 44th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology. Newcastle, Australia: Nephrology; 2008:A101.
Global, regional, and national burden of chronic kidney disease, 1990‐2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395(10225):709‐733.
ISN Global Kidney Health Atlas. International Society of Nephrology; 2023. https://www.theisn.org/wp‐content/uploads/media/ISN%20Atlas_2023%20Digital_REV_2023_04_10.pdf
Liyanage T, Ninomiya T, Jha V, et al. Worldwide access to treatment for end‐stage kidney disease: a systematic review. Lancet. 2015;385(9981):1975‐1982.
McDonald SP, Ullah S, Dansie K, et al. The burden of travel‐time and distance traveled for hemodialysis patients in Australian major city areas. Kidney Int Rep. 2023;8(5):1105‐1108.